China Turns to AI and IVF Tech Falling Birth Rates Alarm
A Chinese biotechnology company is stepping up efforts to combine artificial intelligence (AI) with advanced genetic testing in a bid to improve the success rates of in vitro fertilization (IVF), while also tapping into growing demand for fertility services. The move comes as China faces a deepening birth rate crisis. The firm, BGI Genomics, says it…